News
PYPD
4.753
-1.12%
-0.054
PolyPid to Report First Quarter 2024 Financial Results and Operational Highlights on May 8, 2024
PolyPid Ltd. Will report its first quarter 2024 financial results and operational highlights before the open of the U.S. Financial markets on May 8, 2024. The Company will host a conference call and webcast to discuss the results. PolyPid is a late-stage biopharma company aiming to improve surgical outcomes.
Barchart · 2d ago
Weekly Report: what happened at PYPD last week (0415-0419)?
Weekly Report · 4d ago
BRIEF-Aharon Lukach Reports Passive Stake Of 9.4% In Polypid Ltd As Of January 9, 2024 - SEC Filing
Aharon Lukach Reports Passive Stake Of 9.4% In Polypid Ltd As Of January 9, 2024 - SEC Filing. PolyPid Ltd PYPD.O: Lukach reports passive stake of 9.3% in the company as of January 9. 2024.
Reuters · 04/17 22:26
Weekly Report: what happened at PYPD last week (0408-0412)?
Weekly Report · 04/15 09:41
Analysts Have Conflicting Sentiments on These Healthcare Companies: HCA Healthcare (HCA), PolyPid (PYPD) and Eli Lilly & Co (LLY)
TipRanks · 04/15 08:20
Weekly Report: what happened at PYPD last week (0401-0405)?
Weekly Report · 04/08 09:43
Weekly Report: what happened at PYPD last week (0325-0329)?
Weekly Report · 04/01 09:43
Weekly Report: what happened at PYPD last week (0318-0322)?
Weekly Report · 03/25 09:44
Weekly Report: what happened at PYPD last week (0311-0315)?
Weekly Report · 03/18 09:43
Weekly Report: what happened at PYPD last week (0304-0308)?
Weekly Report · 03/11 09:42
Polypid Ltd.: Annual and transition report of foreign private issuers
Press release · 03/06 22:03
Weekly Report: what happened at PYPD last week (0226-0301)?
Weekly Report · 03/04 09:43
BRIEF-Rosalind Advisors, Inc. Reports 9.95% Passive Stake In Polypid Ltd As Of Feb 13
Reuters · 03/01 18:47
PolyPid Ltd. 13G Filing Shows Rosalind Advisors, Inc. Reported A 9.95% Stake In The Co As Of February 13, 2024
Benzinga · 03/01 17:53
Weekly Report: what happened at PYPD last week (0219-0223)?
Weekly Report · 02/26 09:47
PolyPid Ltd. (PYPD) Upgraded to Buy: What Does It Mean for the Stock?
NASDAQ · 02/19 17:00
Weekly Report: what happened at PYPD last week (0212-0216)?
Weekly Report · 02/19 09:48
Analysts Offer Insights on Healthcare Companies: Anavex Life Sciences (AVXL), PolyPid (PYPD) and Nyxoah (NYXH)
TipRanks · 02/15 11:30
Polypid Ltd.: Report of foreign issuer
Press release · 02/14 20:12
Buy Rating for PolyPid Amid Positive D-PLEX100 Trial Prospects and Strategic Market Positioning
TipRanks · 02/14 16:55
More
Webull provides a variety of real-time PYPD stock news. You can receive the latest news about Polypid Ltd. through multiple platforms. This information may help you make smarter investment decisions.
About PYPD
Polypid Ltd is a biopharmaceutical company at the clinical stage, based in Israel . The company focuses on the development, production and commercialization of new, locally administered therapies to improve surgical results. The main product is PLEX technology, which is located in the place of surgery and ensures controlled and continuous delivery of medicines.